Neuroprotection for Huntington’s Disease: Ready, Set, Slow

This publication has 222 references indexed in Scilit:

• Drug targeting of dysregulated transcription in Huntington's disease
  Progress in Neurobiology, 2007
• Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits
  Proceedings of the National Academy of Sciences, 2007
• A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse
  Proceedings of the National Academy of Sciences, 2007
• Psychiatric disorders in preclinical Huntington's disease
  Journal of Neurology, Neurosurgery & Psychiatry, 2007
• Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation
  BMC Cell Biology, 2007
• Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration
  PLOS Genetics, 2007
• Small molecules enhance autophagy and reduce toxicity in Huntington's disease models
  Nature Chemical Biology, 2007
• OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells
  Nature, 2007
• Proteasome Activator Enhances Survival of Huntington's Disease Neuronal Model Cells
  PLOS ONE, 2007
• Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
  Science, 1997